Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Favorable Outcome of Older Patients with AML and a Favorable Genotype NPM1mut FLT3-ITD Treated with Intensive Chemotherapy: A Subgroup Analysis of Cetlam Protocol 2003 & 2012

Marta Pratcorona, Jordi Lopez-Pardo, MD, Ana Garrido, MD, Salut Brunet, MD PhD, Josep-Maria Ribera, MD PhD, Mar Tormo, MD PhD, Lourdes Escoda, MD PhD, Olga Salamero, Montserrat Arnan, MD PhD, David Gallardo, MD, Joan Bargay, MD, Montserrat Hoyos, PhD, Marina Diaz-Beya, MD PhD, Ruth M Risueño, Josep F. Nomdedeu, MD PhD, Jorge Sierra, MD PhD, Jordi Esteve, MD PhD

Blood (2015) 126 (23): 2511.

https://doi.org/10.1182/blood.V126.23.2511.2511

Published: 2015

Journal Articles

The LincRNA HOTAIRM1 , Located in the HOXA genomic Region , impacts Prognosis in Acute Myeloid Leukemia and Is Associated with a Distinctive microRNA Signature

Marina Díaz-Beyá, MD PhD, Alfons Navarro, PhD, Salut Brunet, MD PhD, Josep F Nomdedeu, MD, Anna Cordeiro, Msc, Marta Pratcorona, MD PhD, Meritxell Nomdedeu, MD PhD, Ruth M Risueño, PhD, Josep-Maria Ribera, MD PhD, Mar Tormo, MDPhD, Rafael F. Duarte, MD PhD, Olga Salamero, MD, Lourdes Escoda, MD, David Gallardo, MD PhD, Carmen Pedro, MD, Josep M Marti-Tutusaus, Jorge Sierra, MD, Mariano Monzó, MD PhD, Jordi Esteve, MD PhD

Blood (2014) 124 (21): 1003.

https://doi.org/10.1182/blood.V124.21.1003.1003

Published: 2014

Journal Articles

Autologous Activated and Expanded Natural Killer Cells Kill Clonogenic Myeloma Cells: A New Therapeutic Option for Multiple Myeloma

Alejandra Leivas, Graduate Student, Ruth M Risueño, PhD, Antonio Pérez-Martínez, MD PhD, María Jesús Blanchard, MD, Dario Campana, MD PhD, Juan José Lahuerta, MD PhD, Joaquín Martínez-López, MD PhD

Blood (2014) 124 (21): 3467.

https://doi.org/10.1182/blood.V124.21.3467.3467

Published: 2014

Journal Articles

Treatment With G-CSF Reduces Acute Myeloid Leukemia (AML) Blasts Viability In Presence Of Bone Marrow Stroma

Meritxell Nomdedeu, MD, PhD, Marta Pratcorona, MD, Marina Díaz-Beyá, MD, Xavier Calvo, MD, Mari Carmen Lara-Castillo, PhD, Daniel Esteban, MD, Maria Rozman, MD, PhD, Dolors Costa, PhD, Jordi Esteve, MD, PhD, Ruth M. Risueño, PhD

Blood (2013) 122 (21): 1422.

https://doi.org/10.1182/blood.V122.21.1422.1422

Published: 2013

Journal Articles

DNMT3A Mutation May Add Prognostic Value To Patients With Acute Myeloid Leukemia Of Intermediate Cytogenetic Risk Harboring a Favorable Genetic Profile Of NPM1 , FLT3 -ITD and CEBPA

Marta Pratcorona, MD, Marina Díaz-Beyá, MD, Meritxell Nomdedeu, MD, PhD, Maria Rozman, MD, Ruth M Risueño, PhD, Jordi Esteve, MD, PhD

Blood (2013) 122 (21): 1339.

https://doi.org/10.1182/blood.V122.21.1339.1339

Published: 2013

Journal Articles

BAALC -Associated Mir-3151 Is An Independent Prognostic Factor In Younger Patients With Intermediate-Risk Cytogenetic Acute Myeloid Leukemia

Marina Díaz-Beyá, MD, Alfons Navarro, PhD, Marta Pratcorona, MD, Salut Brunet, MD, PhD, Josep F Nomdedeu, MD, Josep-Maria Ribera, MD, PhD, Mar Tormo, MD, Rafael F. Duarte, MD, PhD, Olga Salamero, MD, David Gallardo, MD, PhD, Lourdes Escoda, Meritxell Nomdedeu, MD, PhD, Ruth M Risueño, PhD, Montserrat Hoyos, Francisco Cervantes, MD, PhD, Jorge Sierra, MD, PhD, Mariano Monzó, MD, PhD, Jordi Esteve, MD, PhD

Blood (2013) 122 (21): 2577.

https://doi.org/10.1182/blood.V122.21.2577.2577

Published: 2013

Journal Articles

Identification of T-lymphocytic leukemia–initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease

Ruth M. Risueño, Clinton J. V. Campbell, Steve Dingwall, Marilyne Levadoux-Martin, Brian Leber, Anargyros Xenocostas, Mickie Bhatia

Blood (2011) 117 (26): 7112–7120.

https://doi.org/10.1182/blood-2011-01-329078

Published: 2011

Includes: Supplemental data

Journal Articles

Targeting LSCs: powering an old tool

Simona Salati, Ruth M. Risueno, Mickie Bhatia

Blood (2008) 111 (12): 5423–5424.

https://doi.org/10.1182/blood-2008-03-144063

Published: 2008

NARROW

Favorable Outcome of Older Patients with AML and a Favorable Genotype NPM1mut FLT3-ITD Treated with Intensive Chemotherapy: A Subgroup Analysis of Cetlam Protocol 2003 & 2012

The LincRNA HOTAIRM1 , Located in the HOXA genomic Region , impacts Prognosis in Acute Myeloid Leukemia and Is Associated with a Distinctive microRNA Signature

Autologous Activated and Expanded Natural Killer Cells Kill Clonogenic Myeloma Cells: A New Therapeutic Option for Multiple Myeloma

Treatment With G-CSF Reduces Acute Myeloid Leukemia (AML) Blasts Viability In Presence Of Bone Marrow Stroma

DNMT3A Mutation May Add Prognostic Value To Patients With Acute Myeloid Leukemia Of Intermediate Cytogenetic Risk Harboring a Favorable Genetic Profile Of NPM1 , FLT3 -ITD and CEBPA

BAALC -Associated Mir-3151 Is An Independent Prognostic Factor In Younger Patients With Intermediate-Risk Cytogenetic Acute Myeloid Leukemia

Identification of T-lymphocytic leukemia–initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease

Targeting LSCs: powering an old tool

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only